Incidence Of Atrial Fibrillation Significantly Reduced By Candesartan Therapy In Heart Failure Patients

... Osaka, Japan - New data published in the July issue of the American Heart Journal show that candesartan cilexetil (candesartan) is the first angiotensinreceptor blocker (ARB) to significantly reduce the incidence of atrial fibrillation (AF) in a wide spectrum of heart failure patients, includin [click link for full article] ...